Authors:
Monali Tayade, Sampada Kulkarni
Download free PDF
Disposable Incontinence Products Market Size & Share 2026-2035
Report ID: GMI739
|
Published Date: November 2026
|
Report Format: PDF/Excel/Dashboard/Platform
Explore Our Licensing Options:
Disposable Incontinence Products Market
Get a free sample of this report
What are you hoping to find?
Your PDF is on its way. Tell us little about your research goal, and we'll help you find the most relevant market insights.
Disposable Incontinence Products Market Size
The global disposable incontinence products market was valued at USD 15.30 billion in 2025, advancing to USD 16.44 billion in 2026, and is projected to grow at a 7.0% CAGR (2026–2035), reaching USD 30.12 billion by 2035.
Disposable Incontinence Products Market Key Takeaways
Market Leader: Essity led with over 17% market share in 2025.
Leading Players: Top 5 players in this market include Essity, Kimberly-Clark, Coloplast, BD Becton Dickinson, Ontex, which collectively held a market share of 52.5% in 2025.
The disposable incontinence products market is expanding as aging populations, chronic urological conditions, and longer survival with mobility-limiting diseases increase recurring care needs. Demand is also shifting toward clinically differentiated products that support home-based care, reduce caregiver burden, and improve product performance across institutional and consumer channels.
GMI Analyst View
Based on our engagement with industry stakeholders and procurement specialists, the disposable incontinence products market is on track to reach USD 17.64 billion by 2027, reflecting the compounding effect of institutional procurement expansion across acute and long-term care settings alongside accelerating direct-to-consumer sales through digital distribution platforms. This near-term projection signals that demographic volume growth is being reinforced by structural product-mix premiumization, creating a more durable revenue base than volume-only forecasts would suggest.
Disposable Incontinence Products Market Trends, Growth Drivers & GMI Forecast Outlook
The market's outlook rests on a widening care population and a changing treatment mix. Protective garments remain central to daily management, while infection-prevention priorities, digital retail access, and higher-acuity care are increasing the commercial relevance of catheter-based and connected solutions.
Key Drivers
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Population aging affects the market through both patient numbers and treatment intensity. Frailty, reduced mobility, cognitive decline, and longer care episodes increase the likelihood of repeat purchasing, while staffing constraints in residential care encourage products that reduce change frequency and support more predictable care routines.
BPH adds a separate pathway for product demand because its progression often changes the level of urinary management required over time. As clinical intervention, self-catheterization training, and home-based disease management become more common, providers and suppliers can address a broader continuum from absorbent products to precision fluid-management systems.
Technology adoption is increasingly tied to clinical workflow rather than product substitution alone. Hydrophilic coatings, anatomically differentiated designs, and improved drainage configurations can strengthen adherence to catheterization protocols, while connected monitoring products may help care teams identify changes in patient needs before skin integrity and labor-management issues become more acute.
Key Restraints
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Coverage rules can materially influence the economic accessibility of different product categories. In the United States, suppliers serving reimbursed patients must balance documentation requirements, audit exposure, and product availability, which can favor categories with clearer billing pathways over broader consumer-oriented protective garment selections.
The demographic opportunity in lower-income markets is substantial but commercially uneven. Limited reimbursement, lower disposable income, and fragmented distribution restrict the extent to which rising need converts into premium-product penetration, leaving suppliers to weigh long-term market development against near-term channel economics.
Stigma compounds these access constraints by suppressing disclosure and delaying engagement with clinicians or caregivers. Where incontinence is treated as a private issue rather than a manageable health condition, patients are less likely to enter formal care pathways, and retailers have fewer incentives to build visible, differentiated product assortments.
GMI Analyst View
We view the forecast as a divergence between mature markets that can monetize a richer clinical and consumer product mix and emerging markets where demand will expand faster than spending capacity. The decisive commercial variable is not prevalence alone, but whether reimbursement, education, and distribution can convert unmet need into repeat purchasing.
Disposable Incontinence Products Market Segment Analysis
By Product
The disposable incontinence products market generated USD 10.71 billion from protective garments in 2025, and the category is projected to reach USD 20.18 billion by 2035. Its scale reflects the indispensable role of disposable underwear, briefs, and related absorbent formats in routine home care and institutional management, even as higher-acuity devices gain greater revenue relevance.
Diapers accounted for 42.5% of market revenue in 2025 and are projected to represent 40.0% by 2035. The modest share change reflects continued volume demand alongside a shift toward pull-on and anatomically tailored garments that better suit mobile users and self-managed care.
Pads & liners represented a 22.0% share in 2025 and are expected to grow at a 6.5% CAGR. Discretion, portability, and comfort make these formats particularly relevant for ambulatory consumers managing lighter urinary leakage outside institutional settings.
Cloth diapers held 5.5% of market revenue in 2025 and are projected to account for 6.0% by 2035. Their position is shaped by value-conscious purchasing and sustainability considerations, although their use remains distinct from the convenience proposition of single-use protective products.
Urinary catheters generated USD 3.36 billion in 2025 and are projected to reach USD 7.83 billion by 2035. Growth is supported by clinical management needs in urology, neurological care, and long-term care, where product performance, infection prevention, and patient independence influence procurement decisions.
Intermittent catheters represented 10.0% of market revenue in 2025 and are projected to account for 12.0% by 2035. Their expanding role reflects care models that favor periodic bladder emptying and patient self-management where clinically appropriate.
Indwelling catheters held a 9.0% share in 2025 and are anticipated to grow at an 8.1% CAGR. Demand remains linked to acute and high-dependency care, although institutional protocols continue to emphasize appropriate use and timely removal.
External catheters accounted for 3.0% of market revenue in 2025 and are projected to represent 4.0% by 2035. Innovation in wearable urine-management systems is extending their relevance beyond conventional inpatient use into mobility-constrained and home-care settings.
Urine bags generated USD 1.22 billion in 2025 and are forecast to grow at a 5.6% CAGR. These systems remain essential for drainage management, particularly where mobility, overnight care, or longer-duration collection requires reliable capacity and secure connections.
Leg bags represented 5.0% of market revenue in 2025 and are projected to account for 4.5% by 2035. Their importance in daytime mobility remains intact, although product innovation in external collection and monitoring is altering the mix of ambulatory management options.
Bedside bags generated USD 459 million in 2025 and are projected to hold a 2.5% share by 2035. Demand is concentrated in overnight, institutional, and higher-dependency settings, where dependable drainage capacity is more important than extensive product differentiation.
By Application
Urine incontinence generated USD 9.94 billion in 2025 and is projected to represent 62% of market revenue by 2035. The segment's breadth spans light consumer use through clinically managed urinary dysfunction, making it the principal foundation for both protective-garment and catheter demand.
Fecal incontinence accounted for 20% of market revenue in 2025 and is projected to reach USD 6.62 billion by 2035. Greater recognition of the condition in long-term care is increasing the need for specialized containment, skin-care, and caregiver-support solutions.
Dual incontinence generated USD 2.29 billion in 2025 and is expected to grow at a 7.7% CAGR. Patients managing both conditions often require more frequent changes and higher-performance products, increasing the complexity of care planning and product selection.
By Incontinence Type
Stress incontinence generated USD 6.12 billion in 2025 and is projected to represent 37% of market revenue by 2035. The segment is closely associated with women's health and pelvic-floor conditions, supporting demand for discreet, lower-bulk products that fit everyday routines.
Mixed incontinence accounted for 25% of market revenue in 2025 and is projected to represent 26% by 2035. Its clinical complexity can require users to combine product formats as symptoms vary, supporting more sustained consumption across care settings.
Urge incontinence represented 25% of market revenue in 2025 and is projected to reach USD 8.13 billion by 2035. Rising diagnosis of overactive bladder and neurological conditions supports a need for products that manage unpredictable episodes and preserve patient mobility.
Other incontinence types held a 10% share in 2025 and are forecast to grow at a 7.0% CAGR. Continued clinical classification of functional and overflow conditions is widening the range of patients requiring tailored management approaches.
By Disease
Feminine health conditions generated USD 5.35 billion in 2025 and are projected to account for 32% of market revenue by 2035. Demand is shaped by pregnancy, menopause, pelvic-floor dysfunction, and care preferences that favor discreet and skin-sensitive protective formats.
Chronic disease represented 30% of market revenue in 2025 and is projected to reach USD 8.43 billion by 2035. Diabetes, neurological disorders, and mobility-limiting conditions can create long-duration care needs that sustain repeat product utilization.
BPH-related demand generated USD 1.83 billion in 2025 and is projected to represent 16% by 2035. The segment benefits from the age-linked nature of benign prostatic enlargement and the resulting need for escalating urinary-management support.
Mental disorders accounted for 10% of market revenue in 2025 and are forecast to grow at a 7.0% CAGR. Dementia-related loss of continence management capacity increases the role of caregivers and institutions in selecting reliable, easy-to-use products.
Bladder cancer-related products represented 5% of market revenue in 2025 and are projected to reach USD 1.80 billion by 2035. Treatment pathways and post-procedural needs can create specialized demand for urinary-management products and related accessories.
Other diseases accounted for 8% of market revenue in 2025 and are projected to remain at 8% by 2035. This category encompasses diverse conditions whose product requirements vary according to care intensity, mobility, and clinical supervision.
By Material
Super absorbents generated USD 5.81 billion in 2025 and are projected to account for 40% of market revenue by 2035. Their performance is fundamental to higher-capacity garments, particularly where extended wear, leakage control, and skin protection influence purchasing criteria.
Cotton represented 20% of market revenue in 2025 and is projected to reach USD 6.02 billion by 2035. Demand is supported by consumer and caregiver preference for breathable, comfort-oriented products, especially for users with skin sensitivity.
Plastic-based materials generated USD 3.82 billion in 2025 and are projected to represent 22% by 2035. Their role in backsheets, films, and structural components remains important, although sustainability requirements are encouraging material optimization and alternative designs.
Latex accounted for 10% of market revenue in 2025 and is forecast to grow at a 5.9% CAGR. Its functional relevance is strongest in catheter balloons and fittings where elasticity and secure performance are required.
Other materials represented 7% of market revenue in 2025 and are projected to account for 9% by 2035. Nonwoven composites and specialty films offer manufacturers opportunities to differentiate through softness, odor control, fit, and moisture management.
By Gender
Female users generated USD 9.18 billion in 2025 and are projected to account for 58% of market revenue by 2035. Their demand profile spans stress incontinence, menopause-related care, pregnancy-related needs, and consumer-led purchases of discreet absorbent formats.
Male users represented 40% of market revenue in 2025 and are projected to reach USD 12.65 billion by 2035. Expansion is supported by greater demand for BPH-related urinary management and male-specific catheter, external collection, and drainage products.
By Age Group
Below-20 users accounted for 3% of market revenue in 2025 and are forecast to grow at a 7.0% CAGR. Demand is largely associated with congenital urological conditions and neurological disorders that require caregiver-led product selection.
The 20–39 age group generated USD 1.53 billion in 2025 and is projected to represent 10% by 2035. Post-partum care, neurological conditions, and greater willingness to seek early intervention support demand within this cohort.
The 40–59 age group represented 22% of market revenue in 2025 and is projected to reach USD 6.32 billion by 2035. Growing awareness of stress incontinence and access to consumer-oriented products are supporting earlier adoption before more intensive care is required.
The 60–79 age group generated USD 6.88 billion in 2025 and is projected to account for 43% of market revenue by 2035. This cohort is central to market demand because it combines increasing prevalence with sufficient independence to use retail, e-commerce, and clinician-directed purchasing channels.
The 80+ age group represented 20% of market revenue in 2025 and is expected to grow at an 8.5% CAGR. Higher care dependency and elevated product utilization intensity make this cohort particularly important for institutional procurement and premium absorbency requirements.
By Distribution Channel
Retail accounted for 65% of market revenue in 2025 and is projected to represent 55% by 2035. Pharmacies, supermarkets, and medical-supply outlets remain important for immediate access, personal guidance, and purchasing by older consumers and caregivers.
E-commerce represented 35% of market revenue in 2025 and is projected to reach USD 13.55 billion by 2035. Digital channels support discreet ordering, subscription replenishment, broader assortment, and easier comparison of specialized products than conventional retail shelves can provide.
By End Use
Hospitals generated USD 4.59 billion in 2025 and are projected to account for 28% of market revenue by 2035. Acute care demand is tied to surgical procedures, infection-prevention protocols, and the need for standardized products that support clinical workflow.
Nursing facilities represented 25% of market revenue in 2025 and are expected to grow at a 6.6% CAGR. Resident care needs, caregiver workload, and contract purchasing all favor dependable products that can be deployed consistently across large populations.
Long-term care generated USD 3.36 billion in 2025 and is projected to represent 23% of market revenue by 2035. The setting increasingly supports chronic incontinence management outside acute hospitals, creating demand for products that balance performance, cost control, and staff efficiency.
Ambulatory surgical centers accounted for 10% of market revenue in 2025 and are projected to reach USD 3.61 billion by 2035. The continuing shift of urological procedures into outpatient environments raises demand for peri-procedural products and patient education around post-discharge management.
Other end-use settings represented 13% of market revenue in 2025 and are forecast to grow at a 7.0% CAGR. Home care and rehabilitation settings are especially relevant as care delivery moves closer to the patient and purchasing decisions become more distributed.
GMI Analyst View
We see the most meaningful segment shift in the coexistence of two commercial models: clinically specified fluid-management devices serving higher-acuity care and consumer-led protective garments serving daily self-management. Their demand drivers, purchasing authority, and margin structure differ, making channel execution as important as product breadth.
Disposable Incontinence Products Market Regional Analysis
North America Disposable Incontinence Products Market Analysis
The disposable incontinence products market in North America generated USD 5.66 billion in 2025 and is projected to reach USD 9.94 billion by 2035. Established reimbursement infrastructure, institutional purchasing networks, and mature retail access support demand, while clinical quality standards sustain adoption of differentiated catheter and collection technologies.
United States
The United States generated USD 5.20 billion in 2025 and is projected to reach USD 9.14 billion by 2035. Its scale is supported by a substantial skilled-nursing, home-health, and acute-care base, although reimbursement rules continue to shape the mix of accessible products.
Canada
Canada generated USD 459 million in 2025 and is forecast to grow at a 5.6% CAGR. Provincial home-care support and centralized procurement processes favor suppliers able to meet consistent quality, logistics, and contract requirements.
Europe Disposable Incontinence Products Market Analysis
Europe generated USD 4.13 billion in 2025 and is expected to grow at a 5.8% CAGR. Broad healthcare coverage and established clinical pathways create a relatively stable demand base, while regulatory and procurement standards encourage manufacturers to demonstrate product performance and usability.
Germany
Germany generated USD 842 million in 2025 and is forecast to grow at a 5.0% CAGR. Statutory health coverage, an aging population, and a developed home-care ecosystem sustain demand for both absorbent products and catheter systems.
United Kingdom
The United Kingdom generated USD 689 million in 2025 and is projected to reach USD 1.22 billion by 2035. Public procurement provides a dependable institutional base, while private retail and online channels give consumers access to differentiated products outside standardized supply arrangements.
France
France generated USD 612 million in 2025 and is forecast to grow at a 5.2% CAGR. Reimbursement support and the expansion of home-based care are strengthening the role of distribution partners that can serve patients beyond hospital dispensing channels.
Asia Pacific Disposable Incontinence Products Market Analysis
The disposable incontinence products market in Asia Pacific generated USD 4.13 billion in 2025 and is projected to reach USD 9.03 billion by 2035. The region combines mature demand in Japan with institutional-care expansion in China and early-stage consumer-market development in India, making its growth profile commercially diverse.
Japan
Japan generated USD 1.37 billion in 2025 and is forecast to grow at a 0.5% CAGR. A mature domestic supplier base and established care infrastructure limit incremental expansion, even as the country remains an important market for high-quality elderly-care products.
China
China generated USD 1.22 billion in 2025 and is projected to reach USD 2.71 billion by 2035. Institutional aged-care development, rising consumer awareness, and strong digital commerce infrastructure are widening access to branded and premium product formats.
India
India generated USD 459 million in 2025 and is forecast to grow at a 16.3% CAGR. Low current penetration, expanding urban retail, and e-commerce adoption create substantial growth potential, although affordability and awareness remain important constraints.
Latin America Disposable Incontinence Products Market Analysis
Latin America generated USD 765 million in 2025 and is expected to grow at a 10.7% CAGR. Urban retail development, a growing private healthcare base, and greater availability of branded products are improving access, although reimbursement coverage remains uneven across the region.
Brazil
Brazil generated USD 459 million in 2025 and is forecast to grow at a 9.1% CAGR. Private healthcare access, increasing clinical engagement, and wider organized retail distribution are supporting demand in major urban markets.
Middle East & Africa Disposable Incontinence Products Market Analysis
Middle East & Africa generated USD 612 million in 2025 and is forecast to grow at an 11.4% CAGR. Demand is supported by expanding formal healthcare distribution, investment in long-term care in higher-income markets, and a gradually increasing willingness to seek incontinence management.
Saudi Arabia
Saudi Arabia generated USD 230 million in 2025 and is expected to grow at a 7.8% CAGR. Healthcare spending, institutional supply coverage, and investment in long-term care capacity provide a comparatively favorable setting for product adoption within the region.
GMI Analyst View
We expect Asia Pacific to exert the greatest influence on the future regional revenue mix because its markets are expanding through distinct mechanisms: institutional-care investment in China and consumer-channel development in India. North America, meanwhile, retains strategic importance through premiumization and reimbursement-linked procurement rather than population growth alone.
Disposable Incontinence Products Market Share & Competitive Landscape
The disposable incontinence products market share structure is moderately concentrated, with the top five suppliers collectively accounting for approximately 52.5% of market revenue in 2025. Scale advantages arise from brand recognition, institutional contracts, reimbursement expertise, manufacturing capability, and the ability to serve both retail and clinical channels across multiple geographies.
Essity held approximately 17% of global market revenue in 2025. Its TENA franchise benefits from broad protective-garment coverage and established relationships across institutional and retail channels, while its care-management orientation strengthens relevance in professional settings.
Kimberly-Clark accounted for approximately 11.5% of global market revenue in 2025. Its Depend, Poise, and GoodNites brands provide a strong consumer-facing platform, particularly where retail execution, e-commerce visibility, and category familiarity influence purchasing behavior.
Coloplast represented approximately 9% of global market revenue in 2025. Its competitive position is particularly strong in intermittent catheterization, where specialized design, clinician familiarity, and alignment with infection-prevention objectives can create durable qualification barriers.
BD competes in urinary catheter and external collection systems through its Bard and PureWick portfolios. The company's institutional focus positions it well where clinical workflow, acute-care protocols, and technology-enabled urine management influence purchasing decisions.
Cardinal Health plays an important intermediary role through its medical distribution network, giving it relevance in hospital, nursing-facility, and other institutional purchasing pathways. Its channel position can be especially valuable where product availability and procurement reliability matter as much as brand selection.
ConvaTec and Hollister compete through continence-care portfolios that address chronic users, including patients requiring intermittent catheterization or ongoing home-based management. Their product positioning is closely tied to clinical education, user confidence, and support for long-term adherence.
Ontex, Unicharm, MEDLINE, ABENA, Attends, B Braun, FUBURG, and UROCARE serve distinct positions across private-label protective garments, regional consumer brands, institutional distribution, urinary catheter systems, and collection accessories. This competitive breadth leaves room for regional specialists, but also increases pressure on suppliers to differentiate through product performance, channel reach, and dependable fulfillment.
Recent Industry Developments
BD introduced the PureWick Portable Collection System in November 2025 to extend external urine management into ambulatory and home-care use cases. The platform had been adopted by more than 4,500 U.S. hospitals and rehabilitation facilities, and more than 55 million PureWick external catheters had been sold, underscoring the installed base available to support adjacent product adoption [4]BD. "BD Expands PureWick™ Portfolio with First-of-its-Kind Portable Solution." prnewswire.com.
Essity announced the acquisition of Edgewell Personal Care's feminine care business in November 2025 for USD 340 million. The acquired portfolio generated approximately USD 261 million in net sales, expanding Essity's consumer-health presence across incontinence-adjacent categories in the United States and Canada [5]Essity. "Essity acquires Edgewell's feminine care business." prnewswire.com.
Kimberly-Clark announced an agreement to acquire Kenvue in November 2025 in a transaction valued at approximately USD 48.7 billion. The combined organization is expected to have approximately USD 32 billion in annual revenue and target USD 2.1 billion in net synergies, materially broadening Kimberly-Clark's consumer-health portfolio [7]Kenvue Inc. "Kimberly-Clark to Acquire Kenvue." investors.kenvue.com.
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.
Frequently Asked Questions (FAQs):
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Industry journals, trade publications, and specialized media.
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 20+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →